Thymostimulin enhances the natural cytotoxic activity of patients with transitional cell carcinoma of the bladder
✍ Scribed by Luis M. Moltó; Joaquin A. Carballido; Luis Manzano; Carlos Olivier; Maria Lapuerta; Melchor Alvarez-Mon
- Publisher
- Elsevier Science
- Year
- 1993
- Tongue
- English
- Weight
- 514 KB
- Volume
- 15
- Category
- Article
- ISSN
- 0192-0561
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
The cellular immunocompetence was examined by means of the quantitative DNCB hypersensitivity reaction in 152 patients with transitional cell carcinomas of the bladder of Broders grades 1-4. Against a control group of 367 normal controls of both sexes, 85 patients with transitional cell carcinomas o
The first clinical results of an ongoing, prospective trial to determine the value of adjuvant Bestatin immunotherapy in the management of bladder cancer are presented. Patients with nonmetastatic transitional cell carcinoma of the bladder, scheduled for full dose local radiation therapy (64 Gy), we
Lymphocytes from patients with transitional cell carcinoma (TCC) of the urinary bladder are more cytotoxic to bladder tumor cells than to a variety of control cells. This disease-related cytotoxicity has previously been shown to involve several mechanisms and different types of effector cells. To an